Adrienne Nugent logo Cancer Commons logo

Adrienne Nugent

Vice President, Operations, Cancer Commons (USA)


Dr. Nugent is the Vice President of Operations at Cancer Commons, a nonprofit organization dedicated to supporting patients with advanced cancers through personalized, science-driven care. Cancer Commons provides services to help translate complex scientific data into clear, actionable insights for patients and their care teams. In her role, Dr. Nugent oversees operational strategy and program development, ensuring that emerging scientific advances are effectively integrated into patient-centered support. Dr. Nugent received her B.S. in Chemistry and Ph.D. in Genetics and Genomics from Duke University and has held roles across academic, government, and industry settings, giving her a broad perspective on the scientific and clinical landscapes that shape cancer care. She is committed to advancing patient-centered innovation through the nonprofit sector, leveraging scientific expertise to inform individualized treatment strategies and integrate multi-omics data, clinical evidence, and emerging therapies into care decisions. She is passionate about bridging the gap between rapidly evolving cancer science and realworld patient care, with the goal of improving outcomes and empowering patients through personalized medicine.

Adrienne Nugent logo

Adrienne Nugent

Vice President, Operations, Cancer Commons (USA)


Cancer Commons logo

Dr. Nugent is the Vice President of Operations at Cancer Commons, a nonprofit organization dedicated to supporting patients with advanced cancers through personalized, science-driven care. Cancer Commons provides services to help translate complex scientific data into clear, actionable insights for patients and their care teams. In her role, Dr. Nugent oversees operational strategy and program development, ensuring that emerging scientific advances are effectively integrated into patient-centered support. Dr. Nugent received her B.S. in Chemistry and Ph.D. in Genetics and Genomics from Duke University and has held roles across academic, government, and industry settings, giving her a broad perspective on the scientific and clinical landscapes that shape cancer care. She is committed to advancing patient-centered innovation through the nonprofit sector, leveraging scientific expertise to inform individualized treatment strategies and integrate multi-omics data, clinical evidence, and emerging therapies into care decisions. She is passionate about bridging the gap between rapidly evolving cancer science and realworld patient care, with the goal of improving outcomes and empowering patients through personalized medicine.


Why WIN